Organophosphorus insecticides, as Chlorpyrifos (CPF), are widely used in agriculture and against household pests; these compounds receive an increasing consideration as potential endocrine disrupters. The aim of the present study was to examine the potential short-and long-term effects of CPF on thyroid and adrenal glands in CD1 mice following exposure at dose levels not inducing brain acetyl cholinesterase (AchE) inhibition, during gestational and/or postnatal vulnerable phases. Pregnant dams were treated with 0, 3, 6 mg/kg bw/day of CPF on gestational days 15-18. After delivery, pups were treated subcutaneously on postnatal days (PND) 11-14 with: 0, 1, 3 mg/kg bw/day of CPF. Serum thyroxin (T4), thyroid and adrenals histology and histomorphometry were evaluated in dams and in F1 mice. In dams at 6 mg/kg, decreased T4 levels and increased cell height in thyroid were observed, and adrenal histology showed a slightly increased vacuolization in the X-zone. In the F1, shortterm morphological modifications (reduced follicular size at PND 2) and long-term morphological (increased necrotic follicular cells) and biochemical alterations (reduced serum T4 levels) were found at PND 150 with an apparent higher vulnerability of males. For the first time these results indicate that CPF exposure at dose levels not inducing brain AchE inhibition causes thyroid alterations in dams and in F1 CD1 mice. Thyroid may be a sensitive target to CPF developmental exposure possibly leading to long-term effects on thyroid function. Because thyroid plays a pivotal role in mammalian development, these findings can be relevant to humans.
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Several compounds widespread in food and in the environment are known to act as endocrine disrupting chemicals (EDC). Great attention has been given to potential interactions between EDC and the steroid hormone system and to their subsequent effects on gender phenotype and reproductive capability (Mantovani, 2006; Mantovani and Maranghi, 2005) . However, there is also increasing evidence that a wide range of chemicals can interfere with thyroid and adrenal functions (De Angelis et al., 2007; Maranghi et al., 2003) and that the developmental life stages are critically vulnerable to EDC (Mantovani, 2006) . Thyroid hormones regulate a number of biological processes essential for growth, metabolism as well as brain maturation (Bernal et al., 2003) . Chemicals affecting adrenals can also have serious consequences for the organism, including impaired ability to mount an appropriate physiological response to stress or to maintain electrolyte homeostasis. Moreover, the distinct medullary region releases catecholamines involved in blood pressure and blood flow regulation.
Pesticides are of great concern for their potential adverse human health effects also because of their extensive worldwide utilization leading to potentially widespread exposure through residues in food and living environment . Exposure can also occur in children, for example, through breastfeeding or as bystanders (Sanghi et al., 2003) . Most important, several pesticides are EDC, thus they may elicit subtle long-term effects in the developing organism (De Angelis et al., 2007; Mantovani, 2006; Mantovani and Maranghi, 2005) . Organophosphates are a group of widely used insecticides that affect the cholinesterase system (Kwong, 2002) . Although Chlorpyrifos (CPF), a major representative of this group, is increasingly restricted in several industrialized Countries because of its potential adverse effect on fetal and neonatal brain development (Rauh et al., 2006; Slotkin, 2004) , organophosphorus insecticides, including CPF, still account for up to 50% of all pesticide applications worldwide (Casida and Quistad, 2004) .
Several animal studies have demonstrated that gestational and/or postnatal exposures to CPF induce neurobehavioral alterations (Ricceri et al., 2003 Slotkin and Seidler, 2007; Venerosi et al., 2006 mechanisms have been also demonstrated to disrupt brain development (Casida and Quistad, 2004; Meyer et al., 2004) . Limited studies indicate that CPF may affect endocrine system (Jacobsen et al., 2004; Slotkin et al., 2005) . Specifically, a few studies have suggested that CPF may target thyroid and adrenal gland homeostasis both in human and animal models (Jacobsen et al., 2004; Jeong et al., 2006) .
The aim of the present study was to examine the potential long-term effects of CPF on thyroid and adrenal glands following exposure during gestational and/or postnatal vulnerable phases for the developmental neurotoxicity of CPF and for thyroid development in mice (De Felice and Di Lauro, 2004; Garcia et al., 2003) . Neonatal effects were also considered, through intermediate sampling points to support the onset of the possible changes. The exposure levels were selected as they did not induce brain acetyl cholinesterase (AchE) inhibition in mice . Triiodothyronine (T3) and thyroxin (T4) serum levels, thyroid histology and histomorphometry were selected as appropriate parameters to assess thyroid toxicants in mammals (Zoeller et al., 2007) . Moreover adrenal gland histology and histomorphometry were also evaluated as appropriate end points for adrenal toxicity (Harvey et al., 2007) . Male and female mice of outbreed Swiss-derived strain (CD-1, Harlan, S. Pietro al Natisone, Italy) were housed in breeding cages with a 12-h light/dark cycle. Mice were fed a diet (3KE25 GLP basic standard diet purchased from Mucedola, Settimo Milanese, Italy) with normal iodine content (1.1 mg iodine/ kg); food and water were available ad libitum. Females were inspected daily for mating and the presence of vaginal plug was indicated as gestational day (GD) ¼ 0. Fifteen pregnant females were randomly assigned to the three prenatal treatments.
MATERIALS AND METHODS

Animals
CPF (Chem Service, West Chester, PA, purity 98.8%) dissolved in peanut oil was administered to dams from GD 15-18 by oral gavage at dose levels of 0 (vehicle only, M0), 3 (M3), and 6 (M6) mg/kg bw/day. The dose levels were calculated on the basis of the dams' weight on the first day of treatment. The concentration of CPF solutions were calculated in order to supply a volume of 0.01 ml/g, thus providing 0.4-0.5 ml for a dam weighing 40-50 g. Dams were checked daily for clinical signs of intoxication and weighed at mid-gestation and throughout the treatment period. Immediately after the last treatment (GD 18), after local anesthesia with oxybuprocaine, blood samples from the orbital sinus (maximum 400 ll) were collected for the evaluations of serum T4. Given the limited availability of blood at this time, serum T4 was chosen instead of T3 as specific end point because T3 preferentially results from peripheral T4 deiodination rather than from thyroid synthesis. At day of parturition (postnatal day ¼ 0, PND 0) pups were counted, weighed and checked for the presence of external malformations and/or stillbirths. On PND 2, 1-2 pups/sex/litters were sacrificed by ip injection of Pentothal Sodium and thyroid and adrenal glands were excised. Due to the small size of the pups, blood samples could not be taken at this age.
Remaining pups of both sexes were tattooed with blue ink on their limbs for individual identification and randomly assigned to the three postnatal treatments. Within each litter assigned to one prenatal treatment (M0, M3, or M6), one male and one female were randomly assigned to vehicle (P0), one male and one female to CPF 1 mg/kg bw/day (P1) and one male and one female to CPF 3 mg/kg bw/day (P3) treatment (split-litter design). CPF was administered sc in the nape of the neck at a volume of 1 ml/kg from PND 11 to 14. Nine treatment groups were then established: M0P0, M3P0, M6P0, M0P1, M3P1, M6P1, M0P3, M3P3, and M6P3 (Tab 1). Therefore, some specific treatment groups were treated only pre-and only postnatally. The M0 groups (namely M0P1, M0P3) were treated postnatally only; they were used to assess postnatal CPF effects in the absence of maternal (prenatal) exposure. Conversely, the P0 groups (namely M3P0 and M6P0) were treated prenatally only; they were used to assess prenatal CPF effects in the absence of postnatal exposure. The remaining groups (namely M3P1, M3P3, M6P1, and M6P3) were treated both pre-and postnatally. The group M0P0 represents the true control, that is, no CPF exposure.
The pre-and postnatal exposure windows, namely the late gestational phase (GDs 15-18) and the late neonatal stage , are characterized by different central nervous system maturational events and they represent critical phases of susceptibility to CPF action in rodents (Garcia et al., 2003) . Moreover, the completion of thyroid folliculogenesis occurs in the same gestational period (De Felice and Di Lauro, 2004) .
At PND 15 after local anesthesia with oxybuprocaine in F1 pups of both sexes blood samples from the orbital sinus (maximum 400 ll) were collected for the evaluations of serum T4 level. At postpartum day 23 dams were sacrificed by ip injection of Pentothal Sodium; thyroid glands and adrenals were excised. Litters were weaned, housed in cages containing littermates of the same sex and left undisturbed until adulthood.
The full adulthood (PND 150) represented the key sampling point of the study in order to identify long-term effects. Blood samples from F1 animals of both sexes were collected for the evaluations of serum T3 and T4 levels. F1 males and females were sacrificed by ip injection of Pentothal Sodium: thyroid glands and adrenals were excised and fixed in Bouin's solution for histological and histomorphometrical analysis.
Biochemical evaluation of thyroid hormone levels. T3 and T4 serum concentrations were assessed in mouse sera in duplicate by radioimmunological kits purchased from Radim (Pomezia, Italy), following the manufacturer's instructions. The interassay variability was less than 8% for both T3 and T4 assay.
Histology. Thyroid and adrenals of all dams and F1 offspring (PND 2 and PND 150) were fixed in Bouin's solution and stored in 80% ethyl alcohol. They were embedded in paraffin, cut into 5-lm sections and stained with hematoxylin and eosin for the examination under a light microscopy (Nikon microphot FX) with different lenses.
A preliminary semiquantitative evaluation was performed by scoring the alterations observed as þ (slight), þþ (moderate), or þþþ (marked), comparison to controls provided guidance.
The findings of the histological evaluation were also utilized to target a detailed quantitative assessment performed by means of histomorphometry (Maranghi et al., 2003) .
Histomorphometry. Slides of thyroid and adrenals were examined by means of an image analysis system (Arkon by Nikon) applied to an optical microscope (Nikon Microphot FX).
The histomorphometrical parameters in thyroid and adrenals were evaluated according to Maranghi et al. (2003) .
Thyroid. Using a 23 lens we measure total follicular area as the ratio between computer screen area and number of follicles; therefore, the resulting ratio is proportional inversely to the follicular density.
Follicular cell height as the mean ratio of inner and outer area in five randomly selected follicles/sample were measured by 10x lens; in same follicles the mean ratio of inner and outer areas and number of nuclei were measured to evaluate follicular maturation.
Adrenals. Adrenal mouse cortex and medulla were clearly defined with sharp, even though somewhat irregular, boundaries in dams and in F1 offspring 312 DE ANGELIS ET AL.
at PND 150 but not in pups at PND 2. Therefore, at this time it was not possible to perform a histomorphometrical evaluation. The ratio between area of cortex and medulla was calculated using a 23 lens.
Statistical analysis. Data are presented as means ± SD. The general approach to statistical analysis was to test first in an overall model the main effects and interactions of all factors (i.e., period of exposure: prenatal vs. postnatal, dose: 0 vs. medium vs. high level, sex: male vs. female). Successively, lower levels of testing (models with a reduced number of factors) were applied as appropriate.
T3 and T4 data were analyzed by mixed-model ANOVA on the overall group of subjects and on males and females, separately. When analyzing T4 data on pups, ANOVA model included two between-litter factors (prenatal treatment at three levels: M0 vs. M3 vs. M6 and postnatal treatment at three levels: P0 vs. P1 vs. P3) and one within-litter factor (sex at two levels: males vs. females). We did consider postnatal treatment as between-litter factor because each litter contributed to this analysis with two pups only (one male and one female), both belonging to the same postnatal treatment group. Thus, litters were nested within pre-and postnatal treatments and were random blocking factors with respect to sex. Sex was dropped from the model in the separate analyses on males and females.
When analyzing T3, T4, and histomorphometric data on adult mice, ANOVA model included one between-litter factor (prenatal treatment at three levels: M0 vs. M3 vs. M6) and two within-litter factors (postnatal treatment at three levels: P0 vs. P1 vs. P3 and sex at two levels: males vs. females). Litters were nested within prenatal treatment and were random blocking factors with respect to postnatal treatment and sex. Sex was dropped from the model in the separate analyses on males and females. Multiple comparisons were performed using Tukey HSD test. Bonferroni correction was adopted as a standard procedure to adjust for multiple comparisons.
Mann-Whitney U-test was used to analyze histomorphometric data of dams, F1 offspring at PND 2 and PND 150. Histological data were analyzed with two tail Fisher's exact probability test.
RESULTS
Effects on Pregnant Dams
CPF did not produce signs of maternal toxicity and overt signs of cholinergic intoxication. No effects on food consumption were observed during treatment and after parturition. After the last treatment (GD 18), M3 and M6 dams showed a significant higher body weight in comparison to M0 dams (63 ± 7 vs. 52 ± 0.4 g, p < 0.001 and 60 ± 2 vs. 52 ± 0.4 g, p ¼ 0.005, respectively). Number of pups delivered and sex ratio were comparable among the groups. Litters' weight at birth was comparable in CPF-and vehicle-treated groups (data not shown).
As regard thyroid hormone levels, distribution of serum T4 levels detected in M0, M3 and M6 dams at GD 18 is shown in Figure 1A . Specifically, T4 mean value was significantly lower in M6 dams than in M0 and M3 groups (15.2 ± 2.7 vs. 22.9 ± 3.9 ng/ml, p ¼ 0.048, 15.2 ± 2.7 vs. 24.6 ± 5.9 ng/ml, p ¼ 0.015, respectively). No difference between M3 and M0 was observed.
Histological examinations of thyroid showed a trend toward increased colloid foaminess in the top dose dams, even if the difference was not significant (M6: 3/5, M3: 1/5, M0: 0/5). Histomorphometrical examinations of thyroids showed a significant increased follicular cell height again in M6 dams in comparison to M0 (2.32 ± 0.19 vs. 1.89 ± 0.19, p ¼ 0.017) (Fig. 1B) .
Adrenal histology revealed a slightly increased vacuolization in the X-zone of high dose treated group (M6: 3/5; M3: 0/ 5; M0: 1/5), whereas histomorphometrical examinations showed no major modifications of the organ structure (data not shown).
Effects on F1 Pups at PND 2
Male and female pups were evaluated together for histological and histomorphometrical examinations of thyroids, and only for histological evaluation of adrenals. Histological examination of thyroids showed no major modifications of the microscopic structures; histomorphometrical evaluation showed higher follicular density in M6 than M0 pups, as we observed a significantly reduced ratio between computer screen area and number of follicles (1063 ± 237 vs. 1465 ± 376, p < 0.05). However, follicular size and in particular colloid area 
THYROID EFFECTS OF DEVELOPMENTAL CPF EXPOSURE
were significantly reduced in M6 in comparison to M0 pups (85 ± 33 vs. 131 ± 32, p < 0.05).
No significant effects were observed in adrenals (data not shown).
Effects on F1 Pups at PND 15
Pups exposed either prenatally or postnatally to CPF did not differ from vehicle-treated controls as regards body weight gain recorded from PND 11-14 (data not shown).
Mean serum T4 levels detected at PND 15 did not show any significant difference among exposed females (n ¼ 43) and males (n ¼ 40). Moreover, the comparison among the nine groups of exposed pups confirmed the absence of any significant difference in T4 levels (Table 2) .
Effects on F1 Adults at PND 150
No significant treatment-related effects were observed concerning general health, body weight gain and food consumption up to PND 150.
As regards T3 values, no significant interaction sex 3 postnatal treatment was observed in the overall group of animals. However the ANOVA performed separately on each sex showed a significant effect of postnatal treatment both in males and females (p ¼ 0.0276 and p ¼ 0.0196, respectively). Specifically, MxP3 (where Mx stands for ''regardless of the prenatal treatment received'') males presented lower T3 mean levels than MxP0 males (1.02 ± 0.22 ng/ml vs. 1.23 ± 0.38 ng/ ml, p < 0.05 ( Fig. 2A) . On the other hand, MxP3 females showed higher T3 mean levels than MxP0 females (0.91 ± 0.15 ng/ml vs. 0.81 ± 0.18 ng/ml, p < 0.05) (Fig. 2B) .
When T4 data were analyzed, a significant interaction sex 3 prenatal treatment 3 postnatal treatment was observed in the overall groups of mice (F 4,47 ¼ 2.76, p ¼ 0.0384). The ANOVA performed on males showed a significant main effect of postnatal treatment (p ¼ 0.0148). Specifically, the MxP3 exposed males presented lower T4 mean levels than MxP0 (86 ± 17 ng/ml vs. 97 ± 16 ng/ml, p < 0.05) and MxP1 males (86 ± 17 ng/ml vs. 95 ± 22 ng/ml, p < 0.05) (Fig. 3A) . In females no Note. M ¼ dams' treatment at GD 15-18; P ¼ newborns' postnatal treatment at PND 11-14; 0 ¼ 0 mg/kg bw/day; 1 ¼ 1 mg/kg bw/day; 3 ¼ 3 mg/kg bw/ day; 6 ¼ 6 mg/kg bw/day. Note. M ¼ dams' treatment at GD 15-18; P ¼ newborns' postnatal treatment at PND 11-14; 0 ¼ 0 mg/kg bw/day; 1 ¼ 1 mg/kg bw/day; 3 ¼ 3 mg/kg bw/ day; 6 ¼ 6 mg/kg bw/day. significant main effect of postnatal treatment was found (Fig. 3B) .
Serum T3 and T4 levels segregated for the 9 groups of treatments were shown in Tables 3 and 4. Histological examination of thyroids in males showed a dose-dependent higher number of necrotic follicular epithelial cells exfoliated into the lumen and colloidal fluid in relation to prenatal treatment, namely M0Px: 2/11; M3Px: 4/15; M6Px: 5/ 15 vs. M0P0: 0/5 (where Px stands for ''regardless of the postnatal treatment received''). Considering postnatal treatment, only MxP3 group showed an increased number of necrotic cells, namely MxP0: 2/11; MxP1: 1/14; MxP3 8/16 vs. M0P0: 0/5 (Fig. 4) . In females, considering prenatal treatment, an increased number of necrotic cells was present especially in M3Px and M6Px groups: M0Px: 1/10; M3Px: 4/15; M6Px: 4/ 15 vs. M0P0: 0/5. No dose-related effect was observed following postnatal treatment.
Histological finding, namely necrotic follicular epithelial cells exfoliated into the lumen and colloidal fluid, segregated for the nine groups was summarized in Table 5 .
Histomorphometrical analysis showed a dose-dependent increased ratio between computer screen area and number of follicles in males, indicating a reduced follicular density per thyroid area unit, in particular in M3Px (statistically significant) and M6Px versus M0P0 (2842 ± 443 and 2866 ± 517, respectively, vs. 2359 ± 328, p ¼ 0.038 and p ¼ 0.055). There was no effect on follicular size. No significant differences were observed when prenatal treatment effect was considered in females and when postnatal treatment was considered in male and female mice. Nevertheless, ANOVA analysis performed in 1.29 ± 0.27 93 ± 22 1.14 ± 0.24 97 ± 16 1.12 ± 0.30 95 ± 27 P3 1.10 ± 0.21 90 ± 11 0.95 ± 0.22 82 ± 18 1.0 ± 0.24 87 ± 20
Note. M ¼ dams' treatment at GD 15-18; P ¼ newborns' postnatal treatment at PND 11-14; 0 ¼ 0 mg/kg bw/day; 1 ¼ 1 mg/kg bw/day; 3 ¼ 3 mg/kg bw/ day; 6 ¼ 6 mg/kg bw/day. Note. M ¼ dams' treatment at GD 15-18; P ¼ newborns' postnatal treatment at PND 11-14; 0 ¼ 0 mg/kg bw/day; 1 ¼ 1 mg/kg bw/day; 3 ¼ 3 mg/kg bw/ day; 6 ¼ 6 mg/kg bw/day. THYROID EFFECTS OF DEVELOPMENTAL CPF EXPOSURE the overall groups of animals showed a significant interaction between prenatal and postnatal treatment concerning the reduction of follicular density (F 4,28 ¼ 3.16, p ¼ 0.0291).
Histological and histomorphometrical evaluations of adrenal glands showed no major alterations of the microscopic and macroscopic structure (data not shown).
DISCUSSION
The present study showed that exposure of CD1 mice, during critical windows of prenatal and postnatal development, at CPF dose levels below those inhibiting brain AchE, can induce alterations in thyroid. Specifically, in top dose dams, altered T4 levels supported by histological and histomorphometrical thyroid effects were observed. In particular, possible impairment of thyroid function in dams was demonstrated (1) by a significant increase in the height of thyroid follicular epithelium in the top dose dams, possibly reflecting a sustained hypophyseal thyroid stimulating activity in response to even a modest thyroid hypofunction (Capen, 2000) , and (2) by a significant decrease in serum T4 levels in top dose treated (6 mg/kg bw/day) dams when compared with 3 mg/kg bw/day and control dams. Thus, the CPF-induced impairment of maternal thyroid status during pregnancy may have influenced the in utero environment as regard thyroid homeostasis.
In the F1 mice, neonatal and long-term morphological and biochemical thyroid alterations were present. In prenatally exposed pups at PND 2 a significant increase in follicular density, associated to a decreased follicle size, was found in the top dose group (M6). Thus, our results indicate that development and maturation of thyroid can be altered during the early stages of life as a consequence of maternal CPF exposure. Although similar effects were recorded in rat following in utero exposure to alcohol (Yamamoto et al., 1989) and an increased follicular number was reported in mice exposed to propylthiouracil during pregnancy and lactation, further studies are needed to clarify whether the impaired thyroid development may be caused by an impaired maternal thyroid status and/or by a direct effect of intrauterine CPF exposure on fetal thyroid. In this respect, transplacental passage of CPF has been shown in rats with significant concentrations found in fetal brain and liver (Akhtar et al., 2006) . No treatment-related effects on serum T4 levels are detected in late neonatal mice at PND 15, either as a consequence of prenatal treatment and/or as short-term effect of postnatal exposure; this may suggest that further studies are required to clarify the onset of CPF thyroid effects during early life stages.
At full adulthood (PND 150), the key sampling point of the study, long-term effects of CPF exposure were indicated by thyroid morphology and hormone levels. An increased number of necrotic cells exfoliated into lumen of thyroid follicles were found in adult male and female mice, especially in relation with prenatal treatments (M3Px and M6Px) and top postnatal dose (MxP3). Moreover, in males prenatally exposed to CPF at 3 and 6 mg/kg (M3Px and M6Px) histomorphometrical analysis indicated a dose-dependent decreased follicular density. Histopathological findings showed, for the first time, that CPF exposure at dose levels not inducing brain AchE inhibition, during vulnerable developmental phases can cause Note. M ¼ dams' treatment at GD 15-18; P ¼ newborns' postnatal treatment at PND 11-14; 0 ¼ 0 mg/kg bw/day; 1 ¼ 1 mg/kg bw/day; 3 ¼ 3 mg/kg bw/ day; 6 ¼ 6 mg/kg bw/day. 316 long-term thyroid alterations possibly leading to an impaired thyroid function especially in males.
In fact, in both sexes reduced serum T4 levels were found, with the most evident effect being observed in males in relation to postnatal exposure to either 3 or 1 mg/kg bw.
Overall, the effects recorded at adulthood and supported by the alterations observed at PND 2 seem to suggest that the prenatal exposure may affect the thyroid parenchyma architecture early in life. Additional exposure during the first phases of life might contribute to thyroid function failure especially in male adult mice. Similar results have been obtained in other studies conducted in experimental models, although at higher dose levels of CPF than those used in the present study. Specifically, a significant decrease in serum T4 was observed following 36 days of treatment with two weekly doses of 12.5 mg/kg of CPF in ewes (Rawlings et al, 1998) . More recently, Jeong et al. (2006) found decreased T4 levels and histopathological damage-corresponding to vacuolation or necrosis of thyroid follicular epithelial cells-in F1 male rats exposed during pregnancy and for 13 weeks after birth to 10 and 100 mg/kg dose levels of CPF-methyl. A thyreostatic effect of CPF was suggested also by a study conducted on men of reproductive age with fertility problems, showing an inverse association between urinary concentration of CPF metabolites and T4 level and a positive association with TSH (Meeker et al., 2006) .
Although histological and histomorphometrical alterations were observed in adult F1 mice of both sexes, it is important to note that the main effect of postnatal treatment on serum T3 level was in the opposite direction for males (reduced at MxP3) versus females (increased at MxP3). Given the fact that T3 preferentially results from peripheral T4 deiodination rather than from thyroid synthesis, it is possible to hypothesize that peripheral deiodination activity is differentially affected by CPF exposure in males and in females. Indeed a physiological sexual dimorphism in deiodinase activity is recognized in rats (Marassi et al., 2007) .
The sex-selective effect for thyroid hormone production is also evident for thyroid architecture. In fact, a significantly decreased follicular density was found in M3Px and M6Px adult males. These findings are consistent with other studies with CPF showing sex-selective effects on neurobehavioral parameters and insulin levels Slotkin et al., 2005) . However, to our best knowledge, this is the first study showing a gender-specific effect on thyroid gland following CPF exposure during critical developmental phases. This is clearly different from the well-known sex-related difference in CPF acute toxicity that is related to metabolism and leads to higher vulnerability in females (Dalvi et al., 2004) .
CPF effects on adrenal glands were restricted to dams, in which moderately increased vacuolization in the X-zone of high dose group was present. The murine X-zone, showing the features of steroid producing cells, develops after birth and regresses at puberty in male and during the first pregnancy in female rodents. The data recorded in adrenals can be associated with retarded physiological regression of such a tissues leading to steroid accumulation in treated dams (Hershkovitz et al., 2007) . Similar results have been obtained in adult male rats exposed in the diet for 2 years to 10 mg/kg of CPF inducing increased adrenal vacuolation of zona fasciculata (Yano et al., 2000) . Moreover, CPF-methyl induced necrosis and vacuolation in cortical cell of F1 male rats exposed to 10 and 100 mg/ kg during pregnancy and for 13 weeks before sacrifice (Jeong et al., 2006) .
No histological adrenal changes were observed either in neonatal or adult F1 mice. The absence of any treatment-related morphological alteration indicates that adrenals are not a major target for CPF developmental exposure. However, further studies involving biochemical and/or functional biomarkers are needed to confirm such a hypothesis.
It is finally noteworthy that thyroid effects have been induced by other organophosphates in mammals and fish (methamidophos, dimecron) (Satar et al., 2005; Thangavel et al., 2005) ; thus thyroid may deserve attention as target tissue for this class of compounds.
In conclusion, for the first time, our results suggest that CPF administration, at dose levels without effect on brain AchE causes thyroid alterations possibly leading to hypofunction in dams and long-term thyroid changes in F1 mice, with an apparent higher vulnerability in males. The present findings can have important implications for humans, as the thyroid plays a pivotal role in mammalian prenatal as well as postnatal development. A growing body of data support the view that even subtoxic exposures to organophosphates may increase risk of neurobehavioral alterations in children (Eskenazi et al., 2008; Rauh et al., 2006; Young et al., 2005) . Although the aggregated daily exposure to CPF in children has been estimated as much lower than the levels used in our study (0.03 up to 0.3 lg/kg die) (Wilson et al., 2003 ) the impact of a continuous exposure throughout pre-and postnatal development might not be overlooked, as well as the possible additive effects together with other organophosphorus compounds. In addition, our findings suggest that endocrine-related effects may deserve more consideration in the risk assessment of organophosphates. Because CPF as other organophosphates are still widely diffused pesticides worldwide, further investigations in susceptible and vulnerable groups of population, such as pregnant women and children, should be carried out to verify the impact of such a compound on human health. 
